✦ LIBER ✦

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

✍ Scribed by O'Rourke, T.J.; Brown, T.D.; Havlin, K.; Kuhn, J.G.; Craig, J.B.; Burris, H.A.; Satterlee, W.G.; Tarassoff, P.G.; Von Hoff, D.D.

Book ID: 123058049
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 275 KB
Volume: 30
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)90276-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and Pharmacokinetic Study of Fos

Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days

✍ Lyly H. Lê; Charles Erlichman; Linda Pillon; Jake J. Thiessen; Andrew Day; Nancy 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 108 KB

A Phase I clinical trial of ixabepilone

A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days

✍ Sen H. Zhuang; Manish Agrawal; Maureen Edgerly; Susan Bakke; Herb Kotz; Paul Tha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND The epothilones are a novel class of microtubule‐stabilizing agents. Ixabepilone (BMS‐247550; NSC 710428) is a semisynthetic analog of the natural product epothilone B. The authors conducted a Phase I study by administering ixabepilone to patients as a 1‐hour intravenous

302: An Evaluation of DNA Methylation Ch

302: An Evaluation of DNA Methylation Changes in a Phase I Clinical Trial of Low-dose 5-azacitidine (AZA) given as Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

✍ L. Silva; G. Garcia-Manero; S. Giralt; G. McCormick; A. Soriano; R. Champlin; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB